Get API key
Insider trading · Q3 2026 · CIK 1770787

10x Genomics, Inc. (TXG) insider trading.

In Q3 2026, insiders at 10x Genomics, Inc. reported 30 non-derivative transactions on 13 Forms 3, 4 and 5: 0 open-market purchases and 28 sales worth $12.2M.

Transactions
30
Purchases (P)
0
Sales (S)
28
Net shares, P minus S
-186,884
Insiders
6
Last filed
2026-09-24

Insiders

InsiderRelationshipTransactionsBuysSales
Saxonov SergeDirector, Officer · Chief Executive Officer1109
Suliman ShehnaazDirector707
Stuelpnagel John RDirector505
Taich AdamOfficer · Chief Financial Officer404
Teichmann Sarah A.Director202
Hindson Benjamin J.Director, Officer · See Remarks101

Transactions

30 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-22Saxonov SergeS (D)1,000$78.231,074,249Form 4
2026-09-22Saxonov SergeS (D)9,900$81.831,053,049Form 4
2026-09-22Saxonov SergeS (D)9,300$80.91,062,949Form 4
2026-09-22Saxonov SergeS (D)2,000$79.621,072,249Form 4
2026-09-22Saxonov SergeS (D)2,800$82.371,050,249Form 4
2026-09-22Suliman ShehnaazS (D)1,325$80.8227,284Form 4
2026-09-22Suliman ShehnaazS (D)2,270$81.6725,014Form 4
2026-09-22Suliman ShehnaazS (D)292$78.229,223Form 4
2026-09-22Suliman ShehnaazS (D)614$79.5128,609Form 4
2026-09-22Suliman ShehnaazS (D)1,222$82.2823,792Form 4
2026-09-09Taich AdamS (D)1,206$63.68361,526Form 4
2026-09-09Taich AdamS (D)13,754$65.26316,344Form 4
2026-09-09Taich AdamS (D)31,428$64.31330,098Form 4
2026-09-03Stuelpnagel John RS (D)6,814$62.11334,610Form 4
2026-09-03Stuelpnagel John RS (D)7,012$60.66341,424Form 4
2026-09-03Stuelpnagel John RS (D)6,174$62.61328,436Form 4
2026-09-01Saxonov SergeG (D)100$01,075,249Form 4
2026-08-26Saxonov SergeS (D)3,500$63.021,082,335Form 4
2026-08-26Saxonov SergeS (D)6,494$63.981,075,841Form 4
2026-08-26Saxonov SergeS (D)492$64.751,075,349Form 4
2026-08-24Suliman ShehnaazS (D)561$62.7331,161Form 4
2026-08-24Suliman ShehnaazS (D)1,646$63.9729,515Form 4
2026-08-24Hindson Benjamin J.S (D)13,818$63.02488,182Form 4
2026-08-24Taich AdamS (D)17,166$63.02362,732Form 4
2026-08-24Saxonov SergeS (D)18,545$63.021,085,835Form 4
2026-08-20Saxonov SergeG (D)4,000$01,104,380Form 4
2026-08-14Teichmann Sarah A.S (D)2,273$57.1528,058Form 4
2026-08-13Teichmann Sarah A.S (D)5,278$57.2930,331Form 4
2026-08-11Stuelpnagel John RS (D)3,000$58.73348,436Form 4
2026-08-11Stuelpnagel John RS (D)17,000$57.58351,436Form 4

Transaction codes in this quarter

S: 28G: 2

Get TXG insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1770787&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · TXG company page · 10x Genomics, Inc. on SEC.gov

Questions

Are insiders buying or selling 10x Genomics, Inc. (TXG)?

In Q3 2026, insiders at 10x Genomics, Inc. reported 30 non-derivative transactions on 13 Forms 3, 4 and 5: 0 open-market purchases and 28 sales worth $12.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these 10x Genomics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/txg.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.